CALLAN JMB INC (CJMB) Fundamental Analysis & Valuation

NASDAQ:CJMB • US1311001093

Current stock price

1.11 USD
-0.02 (-1.77%)
Last:

This CJMB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CJMB Profitability Analysis

1.1 Basic Checks

  • In the past year CJMB has reported negative net income.
  • In the past year CJMB has reported a negative cash flow from operations.
CJMB Yearly Net Income VS EBIT VS OCF VS FCFCJMB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

  • With a Return On Assets value of -86.15%, CJMB is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
  • CJMB has a worse Return On Equity (-159.60%) than 78.26% of its industry peers.
Industry RankSector Rank
ROA -86.15%
ROE -159.6%
ROIC N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CJMB Yearly ROA, ROE, ROICCJMB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

  • CJMB has a better Gross Margin (36.73%) than 82.61% of its industry peers.
  • CJMB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CJMB Yearly Profit, Operating, Gross MarginsCJMB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40

7

2. CJMB Health Analysis

2.1 Basic Checks

  • CJMB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CJMB remains at a similar level compared to 1 year ago.
  • CJMB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CJMB Yearly Shares OutstandingCJMB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CJMB Yearly Total Debt VS Total AssetsCJMB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • CJMB has an Altman-Z score of -1.54. This is a bad value and indicates that CJMB is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.54, CJMB is doing worse than 73.91% of the companies in the same industry.
  • There is no outstanding debt for CJMB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.54
ROIC/WACCN/A
WACC8.95%
CJMB Yearly LT Debt VS Equity VS FCFCJMB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5M 10M

2.3 Liquidity

  • A Current Ratio of 3.60 indicates that CJMB has no problem at all paying its short term obligations.
  • CJMB has a Current ratio of 3.60. This is amongst the best in the industry. CJMB outperforms 91.30% of its industry peers.
  • CJMB has a Quick Ratio of 3.42. This indicates that CJMB is financially healthy and has no problem in meeting its short term obligations.
  • CJMB's Quick ratio of 3.42 is amongst the best of the industry. CJMB outperforms 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.42
CJMB Yearly Current Assets VS Current LiabilitesCJMB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M

0

3. CJMB Growth Analysis

3.1 Past

  • The earnings per share for CJMB have decreased strongly by -205.15% in the last year.
  • CJMB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.29%.
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-374.49%
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.8%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CJMB Yearly Revenue VS EstimatesCJMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

0

4. CJMB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CJMB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJMB Price Earnings VS Forward Price EarningsCJMB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CJMB Per share dataCJMB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CJMB Dividend Analysis

5.1 Amount

  • CJMB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CJMB Fundamentals: All Metrics, Ratios and Statistics

CALLAN JMB INC

NASDAQ:CJMB (4/14/2026, 10:02:14 AM)

1.11

-0.02 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.13%
Inst Owner Change0%
Ins Owners57.2%
Ins Owner Change0.22%
Market Cap6.25M
Revenue(TTM)5.91M
Net Income(TTM)-6.66M
AnalystsN/A
Price TargetN/A
Short Float %5.5%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS1.05
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -86.15%
ROE -159.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.73%
FCFM N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 397.23%
Cap/Sales 10.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.42
Altman-Z -1.54
F-Score3
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)375.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-374.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-203.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-92.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.28%
OCF growth 3YN/A
OCF growth 5YN/A

CALLAN JMB INC / CJMB Fundamental Analysis FAQ

What is the fundamental rating for CJMB stock?

ChartMill assigns a fundamental rating of 2 / 10 to CJMB.


What is the valuation status of CALLAN JMB INC (CJMB) stock?

ChartMill assigns a valuation rating of 0 / 10 to CALLAN JMB INC (CJMB). This can be considered as Overvalued.


How profitable is CALLAN JMB INC (CJMB) stock?

CALLAN JMB INC (CJMB) has a profitability rating of 1 / 10.


Can you provide the financial health for CJMB stock?

The financial health rating of CALLAN JMB INC (CJMB) is 7 / 10.